The Journal of Japan Atherosclerosis Society
Online ISSN : 2185-8284
Print ISSN : 0386-2682
ISSN-L : 0386-2682
Clinical Significance of Serum Apolipoprotein H (β2-glycoprotein I) in NIDDM
Kazunaga TAKAMATSUMasui KAWADATadashi SUEHIRONobukazu YASUOKAKenzo YOSHIDATamotsu NISHIYAMAIssui UETATakashi ITAHARAFumihiko TANIOKAFumitoshi OHNO
Author information
JOURNAL OPEN ACCESS

1987 Volume 15 Issue 1 Pages 241-247

Details
Abstract
We determined serum apolipoprotein H concentration in non insulin dependent diabetes mellitus (NIDDM) by a single radial immunodiffusion and evaluated the clinical significance of apolipoprotein H.
Apolipoprotein H levels in NIDDM (73 cases, age: 59.5±13.1 years) was 24.8±6.7mg/dl, did not differ from 24.7±3.7mg/dl in healthy group (23 cases, age: 56.3±6.2 years). Apolipoprotein H levels were not depend on the levels of blood glucose and the kinds of therapeutic of diabetes.
Apolipoprotein H levels had a significant positive relationship to serum triglyceride (TG) levels and very low density lipoprotein (VLDL)-TG levels (r=0.418; p<0.001, r=0.385; p<0.001 respectively), but negatively correlated with VLDL-cholesterol/VLDL-TG ratio (r=-0.427, p<0.001). As regards to the main components of TG-rich lipoprotein, apolipoprotein H levels had a significant positive relationship to apolipoprotein C-II, C-III and E levels (r=0.424, 0.590, 0.406 respectively, all of p<0.001).
On the basis of these data, apolipoprotein H may have an important role in regulating the TG-rich lipoprotein metabolism in patients with NIDDM.
Content from these authors
© Japan Atherosclerosis Society

This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
https://creativecommons.org/licenses/by-nc-sa/4.0/
Previous article Next article
feedback
Top